Bob Dunn
About Bob Dunn
Bob Dunn is a Senior Director of Toxicology at CytomX Therapeutics with over 20 years of experience in drug development. He holds a Ph.D. in Physiology and is a board-certified toxicologist, having previously worked at Charles River Laboratories and Amgen.
Work at CytomX Therapeutics
Bob Dunn serves as the Senior Director of Toxicology at CytomX Therapeutics, a position he has held since 2020. Located in South San Francisco, California, he is responsible for overseeing toxicology-related aspects of drug development. His role involves ensuring the safety and efficacy of therapeutic candidates throughout the development process. Dunn's extensive experience in toxicology contributes to the company's mission of advancing innovative cancer therapies.
Previous Experience at Charles River Laboratories
Prior to his current role, Bob Dunn worked at Charles River Laboratories as the Senior Director of Toxicology from 2017 to 2020. In this capacity, he managed toxicology studies and contributed to the development of drug candidates. His leadership in toxicology during this period helped enhance the company's capabilities in preclinical testing.
Career at Amgen
Bob Dunn was employed at Amgen as a Principal Scientist from 2003 to 2017. During his 14 years at the company, he played a significant role in drug development projects, focusing on toxicology and safety assessments. His work at Amgen further solidified his expertise in the field and contributed to the advancement of various therapeutic products.
Education and Expertise
Bob Dunn has a robust educational background in toxicology and related fields. He earned a Ph.D. in Physiology from Saint Louis University School of Medicine, where he studied from 1990 to 1995. He also completed a Postdoctoral Fellowship in Toxicology at the University of Kansas Medical Center from 1995 to 1998. Additionally, he holds a Bachelor's degree in Biology from Rockhurst University, obtained from 1985 to 1989. Dunn is a board-certified toxicologist, reflecting his recognized expertise in the discipline.
Background in Drug Development
With over 20 years of experience in drug development, Bob Dunn has been involved in all phases of the process since at least 1995. His extensive background encompasses various aspects of toxicology, including safety assessments and regulatory compliance. This long-standing commitment to the field has equipped him with the knowledge and skills necessary to navigate complex challenges in drug development.